Dapagliflozin improves cardiometabolic outcomes in myocardial infarction Presented ByProf. Stefan James, Uppsala University, Sweden TrialPhase 3, DAPA-MI ConferenceAHA 2023 TypePeer-reviewed article 29 January 2024 13:33